当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析 - 现金流量表

川宁生物

(301301)

  

流通市值:77.35亿  总市值:278.76亿
流通股本:6.19亿   总股本:22.30亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金620,005,079.474,653,467,257.763,108,948,836.092,168,902,930.68
  收到的税费返还020,662,248.911,185,342.771,185,342.77
  收到其他与经营活动有关的现金28,158,410.87108,982,515.7255,526,536.8641,473,024.68
  经营活动现金流入小计648,163,490.344,783,112,022.393,165,660,715.722,211,561,298.13
  购买商品、接受劳务支付的现金199,143,610.831,688,602,393.041,374,076,632.27824,178,246
  支付给职工以及为职工支付的现金159,333,188.58487,314,482.1338,659,024.58252,053,405.6
  支付的各项税费167,563,156.57669,136,122.55572,306,170.75353,434,611.54
  支付其他与经营活动有关的现金5,538,993.84146,991,748.355,359,218.689,468,564.36
  经营活动现金流出小计531,578,949.822,992,044,746.042,290,401,046.281,439,134,827.5
  经营活动产生的现金流量净额116,584,540.521,791,067,276.35875,259,669.44772,426,470.63
二、投资活动产生的现金流量:
  收回投资收到的现金200,464,358.91205,506,853.08200,000,000-
  取得投资收益收到的现金-631,1001,145,426.03246,200
  处置固定资产、无形资产和其他长期资产收回的现金净额-46,180.51--
  投资活动现金流入小计200,464,358.91206,184,133.59201,145,426.03246,200
  购建固定资产、无形资产和其他长期资产支付的现金10,215,903.2942,601,377.7877,828,060.1335,611,589.81
  投资支付的现金412,750,000269,800,000234,800,00034,800,000
  投资活动现金流出小计422,965,903.29312,401,377.78312,628,060.1370,411,589.81
  投资活动产生的现金流量净额-222,501,544.38-106,217,244.19-111,482,634.1-70,165,389.81
三、筹资活动产生的现金流量:
  吸收投资收到的现金-26,191,92026,191,92020,260,920
  其中:子公司吸收少数股东投资收到的现金-5,931,0005,931,000-
  取得借款收到的现金-780,000,000690,000,000320,000,000
  筹资活动现金流入小计0806,191,920716,191,920340,260,920
  偿还债务支付的现金22,333,3331,561,333,3331,023,333,333299,843,750
  分配股利、利润或偿付利息支付的现金6,418,022.04545,072,524.74536,133,748.42526,073,005.63
  支付其他与筹资活动有关的现金-60,855,230.460,855,230.460,855,230.4
  筹资活动现金流出小计28,751,355.042,167,261,088.141,620,322,311.82886,771,986.03
  筹资活动产生的现金流量净额-28,751,355.04-1,361,069,168.14-904,130,391.82-546,511,066.03
四、汇率变动对现金及现金等价物的影响1,905,343.16,537,247.241,255,140.022,995,954.97
五、现金及现金等价物净增加额-132,763,015.8330,318,111.26-139,098,216.46158,745,969.76
  加:期初现金及现金等价物余额1,085,404,379.06758,013,563.35758,013,563.35758,013,563.35
  期末现金及现金等价物余额952,641,363.261,088,331,674.61618,915,346.89916,759,533.11
补充资料:
  净利润-1,400,350,219.97-766,327,623.76
  资产减值准备-10,387,988.59-8,195,674.59
  固定资产和投资性房地产折旧-519,591,217.3-251,083,836.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-519,591,217.3-251,083,836.08
  无形资产摊销-22,151,665.61-12,506,284.11
  长期待摊费用摊销-878,253-439,126.5
  处置固定资产、无形资产和其他长期资产的损失---0
  固定资产报废损失-1,247,122.82-479,728.22
  公允价值变动损失--31,500-224,600
  财务费用-55,373,012.79-31,274,846.47
  投资损失--358,468.07--140,640.44
  递延所得税-460,728.5--5,607,519.2
  其中:递延所得税资产减少-768,004.49--5,394,800.57
    递延所得税负债增加--307,275.99--212,718.63
  存货的减少-317,295,353.6-747,368,101.44
  经营性应收项目的减少--557,510,093.81--906,547,703.8
  经营性应付项目的增加--7,987,519.08--141,264,568.71
  其他-12,494,626.76-0
  不涉及现金收支的投资和筹资活动金额其他项目-311,206,323.31--
  现金的期末余额-1,088,331,674.61-916,759,533.11
  减:现金的期初余额-758,013,563.35-758,013,563.35
  现金及现金等价物的净增加额-330,318,111.26-158,745,969.76
公告日期2025-04-292025-04-222024-10-222024-08-27
审计意见(境内)标准无保留意见
TOP↑